BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 8085156)

  • 1. Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors.
    Cáceres JF; Stamm S; Helfman DM; Krainer AR
    Science; 1994 Sep; 265(5179):1706-9. PubMed ID: 8085156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of exon skipping and inclusion by heterogeneous nuclear ribonucleoprotein A1 and pre-mRNA splicing factor SF2/ASF.
    Mayeda A; Helfman DM; Krainer AR
    Mol Cell Biol; 1993 May; 13(5):2993-3001. PubMed ID: 8474457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. hnRNP A1 and the SR proteins ASF/SF2 and SC35 have antagonistic functions in splicing of beta-tropomyosin exon 6B.
    Expert-Bezançon A; Sureau A; Durosay P; Salesse R; Groeneveld H; Lecaer JP; Marie J
    J Biol Chem; 2004 Sep; 279(37):38249-59. PubMed ID: 15208309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative splicing of the adenylyl cyclase stimulatory G-protein G alpha(s) is regulated by SF2/ASF and heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1) and involves the use of an unusual TG 3'-splice Site.
    Pollard AJ; Krainer AR; Robson SC; Europe-Finner GN
    J Biol Chem; 2002 May; 277(18):15241-51. PubMed ID: 11825891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of alternative pre-mRNA splicing by hnRNP A1 and splicing factor SF2.
    Mayeda A; Krainer AR
    Cell; 1992 Jan; 68(2):365-75. PubMed ID: 1531115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of alternative 5' splice sites: role of U1 snRNP and models for the antagonistic effects of SF2/ASF and hnRNP A1.
    Eperon IC; Makarova OV; Mayeda A; Munroe SH; Cáceres JF; Hayward DG; Krainer AR
    Mol Cell Biol; 2000 Nov; 20(22):8303-18. PubMed ID: 11046128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulated tissue-specific expression of antagonistic pre-mRNA splicing factors.
    Hanamura A; Cáceres JF; Mayeda A; Franza BR; Krainer AR
    RNA; 1998 Apr; 4(4):430-44. PubMed ID: 9630249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HnRNP A1/A2 and SF2/ASF regulate alternative splicing of interferon regulatory factor-3 and affect immunomodulatory functions in human non-small cell lung cancer cells.
    Guo R; Li Y; Ning J; Sun D; Lin L; Liu X
    PLoS One; 2013; 8(4):e62729. PubMed ID: 23658645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exon identity established through differential antagonism between exonic splicing silencer-bound hnRNP A1 and enhancer-bound SR proteins.
    Zhu J; Mayeda A; Krainer AR
    Mol Cell; 2001 Dec; 8(6):1351-61. PubMed ID: 11779509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular and viral splicing factors can modify the splicing pattern of CFTR transcripts carrying splicing mutations.
    Nissim-Rafinia M; Chiba-Falek O; Sharon G; Boss A; Kerem B
    Hum Mol Genet; 2000 Jul; 9(12):1771-8. PubMed ID: 10915765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles for SR proteins and hnRNP A1 in the regulation of c-src exon N1.
    Rooke N; Markovtsov V; Cagavi E; Black DL
    Mol Cell Biol; 2003 Mar; 23(6):1874-84. PubMed ID: 12612063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. hnRNP A1 functions with specificity in repression of SMN2 exon 7 splicing.
    Kashima T; Rao N; David CJ; Manley JL
    Hum Mol Genet; 2007 Dec; 16(24):3149-59. PubMed ID: 17884807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stress-induced nuclear bodies are sites of accumulation of pre-mRNA processing factors.
    Denegri M; Chiodi I; Corioni M; Cobianchi F; Riva S; Biamonti G
    Mol Biol Cell; 2001 Nov; 12(11):3502-14. PubMed ID: 11694584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SRp30c is a repressor of 3' splice site utilization.
    Simard MJ; Chabot B
    Mol Cell Biol; 2002 Jun; 22(12):4001-10. PubMed ID: 12024014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The A1 and A1B proteins of heterogeneous nuclear ribonucleoparticles modulate 5' splice site selection in vivo.
    Yang X; Bani MR; Lu SJ; Rowan S; Ben-David Y; Chabot B
    Proc Natl Acad Sci U S A; 1994 Jul; 91(15):6924-8. PubMed ID: 8041722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of the SR proteins ASF/SF2 and SC35 influences alternative splicing in vivo in diverse ways.
    Wang J; Manley JL
    RNA; 1995 May; 1(3):335-46. PubMed ID: 7489505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatio-temporal expression of the trans-acting splicing factors SF2/ASF and heterogeneous ribonuclear proteins A1/A1B in the myometrium of the pregnant human uterus: a molecular mechanism for regulating regional protein isoform expression in vivo.
    Pollard AJ; Sparey C; Robson SC; Krainer AR; Europe-Finner GN
    J Clin Endocrinol Metab; 2000 May; 85(5):1928-36. PubMed ID: 10843177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of hnRNP A1 alternative splicing: an intron element represses use of the common 3' splice site.
    Simard MJ; Chabot B
    Mol Cell Biol; 2000 Oct; 20(19):7353-62. PubMed ID: 10982852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of 3' splice site choice in vivo by ASF/SF2 and hnRNP A1.
    Bai Y; Lee D; Yu T; Chasin LA
    Nucleic Acids Res; 1999 Feb; 27(4):1126-34. PubMed ID: 9927747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of Ich-1 pre-mRNA alternative splicing and apoptosis by mammalian splicing factors.
    Jiang ZH; Zhang WJ; Rao Y; Wu JY
    Proc Natl Acad Sci U S A; 1998 Aug; 95(16):9155-60. PubMed ID: 9689050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.